Dilated Cardiomyopathy in Children: Early Detection and Treatment
Pulmonary Embolism
Pulmonary embolism occurs when an embolus breaks away from a thrombus and blocks the pulmonary artery, generating symptoms that include shortness of breath, chest pain, fainting and haemoptysis. This animation describes the risk factors, mechanisms and treatment of pulmonary embolism. Find more information on pulmonary embolism and other vaso-occlusive disorders here.
This Nature Video is editorially independent. It is produced with third party financial support. Read more about Supported Content here.
Sponsored by Portola Pharmaceuticals.
Apple Watch Warns Of Pulmonary Thrombosis During Sleep And Saves The Life Of The Wearer
Jun 20, 2023 15:00:00
Apple Watch has a function to measure heart rate, and after checking it regularly, it will notify you if it detects an irregular heart rate. So far, there have been reports of
saving the life of the wearer, such as saving the life of a woman who didn't realize she had a heart attack, or helping a teenage sports boy detect heart disease. , A new 29-year-old woman has been reported to have saved her life by Apple Watch.Apple Watch saves local woman's life from deadly blood clotWKRChttps://local12.Com/newsletter-daily/apple-watch-saves-local-womans-life-from-deadly-blood-clot-kimmie-watkins-smartwatch-uc-college-medicine-study-becker-doctor- richard-heart-health-cincinnati-ohio
Apple Watch alerts 29-year-old Cincinnati woman to blood clot in lungs while sleeping - 9to5Machttps://9to5mac.Com/2023/06/19/apple-watch-blood-clot-sleeping/
Kimmy Watkins, who lives in Cincinnati, Ohio, USA, was saved by Apple Watch this time. According to local media WKRC, Mr. Watkins felt strong dizziness in the morning of one day, so he decided to spend the day sleeping. Watkins had no history of heart disease, so he thought the ill health was simply hunger.
Mr. Watkins always measured the heart rate with Apple Watch, but while the resting heart rate of adults is said to be 60 to 80 times, it has risen to 178 beats per minute. . Apple Watch has a function that notifies you when your heart rate rises sharply, and Watkins said he woke up with a notification from Apple Watch.
'I was asleep for about an hour and a half and woke up with a notification that my heart rate was too high for a long time. My heart rate was high for more than 10 minutes,' Watkins said. After that, when I was examined at the hospital immediately, Mr. Watkins was diagnosed as suffering from 'saddle pulmonary thromboembolism'.
Saddle pulmonary thromboembolism is a disease in which blood vessels in the left and right lungs are blocked by saddle-shaped blood clots. According to Dr. Richard Becker, a cardiologist at the University of Cincinnati School of Medicine, the survival rate for saddle pulmonary embolism is 50%. In addition, Mr. Watkins was found to have a coagulopathy, which is prone to blood clots, and an anticoagulant was prescribed.
Watkins said, ``I was very lucky. .
Acute Pulmonary Embolism Market And Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies And Patient Based Forecast By DelveInsight
"Acute Pulmonary Embolism Market"
(Albany, USA) DelveInsight's "Acute Pulmonary Embolism Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Acute Pulmonary Embolism, historical and forecasted epidemiology as well as the Acute Pulmonary Embolism market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Acute Pulmonary Embolism market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Acute Pulmonary Embolism market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Acute Pulmonary Embolism treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Acute Pulmonary Embolism market.
Request for a Free Sample Report @ Acute Pulmonary Embolism Market Forecast
Some facts of the Acute Pulmonary Embolism Market Report are:
Acute Pulmonary Embolism Overview
Acute pulmonary embolism (PE) is a potentially life-threatening condition characterized by the sudden blockage of one or more pulmonary arteries in the lungs. It occurs when a blood clot, typically from the deep veins of the legs (deep vein thrombosis), travels through the bloodstream and lodges in the arteries supplying the lungs. This obstruction disrupts blood flow and impairs oxygen exchange, leading to symptoms such as chest pain, shortness of breath, and rapid heart rate. Prompt diagnosis and treatment are crucial to prevent complications and minimize the risk of death. Treatment options include anticoagulant therapy, thrombolytic therapy, and in some cases, surgical intervention.
Learn more about Acute Pulmonary Embolism treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.Delveinsight.Com/sample-request/acute-pulmonary-embolism-market
Acute Pulmonary Embolism Market
The Acute Pulmonary Embolism market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Acute Pulmonary Embolism market trends by analyzing the impact of current Acute Pulmonary Embolism therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Acute Pulmonary Embolism market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Acute Pulmonary Embolism market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Acute Pulmonary Embolism market in 7MM is expected to witness a major change in the study period 2019-2032.
Acute Pulmonary Embolism Epidemiology
The Acute Pulmonary Embolism epidemiology section provides insights into the historical and current Acute Pulmonary Embolism patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Acute Pulmonary Embolism market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Acute Pulmonary Embolism Epidemiology @ https://www.Delveinsight.Com/sample-request/acute-pulmonary-embolism-market
Acute Pulmonary Embolism Drugs Uptake
This section focuses on the uptake rate of the potential Acute Pulmonary Embolism drugs recently launched in the Acute Pulmonary Embolism market or expected to be launched in 2019-2032. The analysis covers the Acute Pulmonary Embolism market uptake by drugs, patient uptake by therapies, and sales of each drug.
Acute Pulmonary Embolism Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Acute Pulmonary Embolism market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Acute Pulmonary Embolism Pipeline Development Activities
The Acute Pulmonary Embolism report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Acute Pulmonary Embolism key players involved in developing targeted therapeutics.
Request for a sample report to understand more about the Acute Pulmonary Embolism pipeline development activities @ https://www.Delveinsight.Com/sample-request/acute-pulmonary-embolism-market
Acute Pulmonary Embolism Therapeutics Assessment
Major key companies are working proactively in the Acute Pulmonary Embolism Therapeutics market to develop novel therapies which will drive the Acute Pulmonary Embolism treatment markets in the upcoming years are Penumbra Inc., Angiodynamics, Angde Biotech Pharmaceutical Co., Agen Biomedical, Daiichi Sankyo, Tasly Biopharmaceuticals, Eisai Inc., Boston Scientific Corporation, Thrombolex, Inc., Bayer, and others.
Learn more about the emerging Acute Pulmonary Embolism therapies & key companies @ https://www.Delveinsight.Com/sample-request/acute-pulmonary-embolism-market
Acute Pulmonary Embolism Report Key Insights
1. Acute Pulmonary Embolism Patient Population
2. Acute Pulmonary Embolism Market Size and Trends
3. Key Cross Competition in the Acute Pulmonary Embolism Market
4. Acute Pulmonary Embolism Market Dynamics (Key Drivers and Barriers)
5. Acute Pulmonary Embolism Market Opportunities
6. Acute Pulmonary Embolism Therapeutic Approaches
7. Acute Pulmonary Embolism Pipeline Analysis
8. Acute Pulmonary Embolism Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Acute Pulmonary Embolism Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Acute Pulmonary Embolism Competitive Intelligence Analysis
4. Acute Pulmonary Embolism Market Overview at a Glance
5. Acute Pulmonary Embolism Disease Background and Overview
6. Acute Pulmonary Embolism Patient Journey
7. Acute Pulmonary Embolism Epidemiology and Patient Population
8. Acute Pulmonary Embolism Treatment Algorithm, Current Treatment, and Medical Practices
9. Acute Pulmonary Embolism Unmet Needs
10. Key Endpoints of Acute Pulmonary Embolism Treatment
11. Acute Pulmonary Embolism Marketed Products
12. Acute Pulmonary Embolism Emerging Therapies
13. Acute Pulmonary Embolism Seven Major Market Analysis
14. Attribute Analysis
15. Acute Pulmonary Embolism Market Outlook (7 major markets)
16. Acute Pulmonary Embolism Access and Reimbursement Overview
17. KOL Views on the Acute Pulmonary Embolism Market
18. Acute Pulmonary Embolism Market Drivers
19. Acute Pulmonary Embolism Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.Delveinsight.Com/consulting
Press Release Distributed by ABNewswire.Com To view the original version on ABNewswire visit: Acute Pulmonary Embolism Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Patient based Forecast by DelveInsight
© 2023 Benzinga.Com. Benzinga does not provide investment advice. All rights reserved.
Comments
Post a Comment